






Athyrium Capital Management | Athyrium Opportunities Fund (AOF)











 


Investor Login

AOF I Portal
AOF II Portal






   



Athyrium Opportunities Fund (AOF)




 






AOF II


AOF I
 
Previous Investments





Athyrium Opportunities Fund1


Company
Marketer / Counterparty
Product
Initial Investment Date


MedPro Safety Products
Greiner Bio-One
Vacuette Safety System
February 2012


BioFire Diagnostics
BioFire
FilmArray
September 2012


Verenium
Verenium
Various
December 2012


Ironwood Pharmaceuticals
Ironwood and Forest Laboratories
Linzess
January 2013


SynCardia Systems, Inc.
SynCardia
Total Artificial Heart
March 2013


Progenity, Inc.
Progenity, Inc.
Various Genetic Tests
June 2013


Tria Beauty, Inc.
Tria Beauty
Skincare Products
July 2013


InnoPharma, Inc.
Various Marketing Partners
Specialty Injectable and Ophthalmic Generic Pharmaceuticals
October 2013


Horizon Pharma, Inc.
Horizon Pharma
Various NSAIDs and ACTIMMUNE
November 2013


Universal Biosensors, Inc.
LifeScan (J&J) and Siemens
Point of Care (POC) Diagnostics
December 2013


Pernix Therapeutics Holdings, Inc.
Pernix
Treximet and Others
February 2014


Ikaria, Inc.
Ikaria
INOMAX
February 2014


VIVUS, Inc.
VIVUS, Inc.
Qsymia and STENDRA/SPEDRA
February 2014


Synarc-Biocore Holdings, LLC
Synarc-Biocore Holdings
Specialty Clinical Research Services
March 2014


Retrophin, Inc.
Alamo Pharma Services, Inc.
Chenodal / Thiola
July 2014


Tecomet, Inc.
Tecomet
Orthopedic and Other Contract Manufacturing Services
December 2014


Zealand Pharma A/S
Sanofi
Lyxumia
December 2014


Lannett Company, Inc.
Lannett Company, Inc.
Generic Pharmaceuticals
December 2015


1. This table lists all investments made by the Athyrium Opportunities Fund.







 
 

 





Home - MedPro Safety Products - MPSP



















MedPro



ABOUT US
BOARD OF DIRECTORSNEWS AND ANNOUNCEMENTSCONTACT US  
INVESTOR RELATIONS






Safety


Products
DRUG DELIVERYPHLEBOTOMYAMBIENATIVANKLONOPINMERIDIASOMATRAMADOLVALIUMXANAX  

145 Rose
















News & Annoucements


All News & Annoucements
Previous
Next












MedPro Agrees to Sell Patents on Three Blood Collection and Infusion Products to Greiner Bio-One



Agreement will also eliminate $30 million of MedPro long-term debt

» READ MORE







MedPro Makes Charitable Donation to Sandy Hook in Lieu of Sending Holiday Cards



Happy Holidays from MedPro!

» READ MORE







Find MedPro at CPHI in Madrid



Meet us at Innopack / ICSE booth 10J47.  This event is located at the Feria Madr

» READ MORE











MedPro Safety Products and Weimer Pharma Announce Marketing Partnership



Lexington, KY / Rastatt, Germany – August 2, 2012 – MedPro Safety Products, Inc.

» READ MORE







MedPro Signs Letter of Intent with Specialty Pharmaceutical Company



Lexington, KY – July 16, 2012 – MedPro Safety Products, Inc. (OTCBB:MPSP), a lea

» READ MORE







Crystal Research Provides Update on MedPro Safety Products



Recent Update on MedPro Safety Products Published by Crystal Research Reports

» READ MORE











MedPro Safety Products to Participate in Two Key Industry Conferences



Company to Highlight Its Innovative Drug Delivery Solutions at 2012 AAPS Nationa

» READ MORE







MedPro Featured in Drug Development & Delivery May Issue



"Prefilled Syringes - A Container of Choice for Pharma" Features MedPro's Prefil

» READ MORE







Whitepaper Featured on Occupational Health & Safety Website



"A Call to Safety: Why Current Safety Devices are Not Solving the Needlestick Is

» READ MORE











MedPro Safety Products Releases 2011 Financial Results



Reports on Progress and Recent Corporate Developments

» READ MORE







Survey Reveals Market Demand for New Prefilled Drug Delivery Platform



MedPro Seeks Partnerships to Commercialize New Cartridge Platform, Safety Syring

» READ MORE







ONdrugDelivery Publication Features MedPro Article



Download MedPro's Feature Article in ONdrugDelivery.

» READ MORE


















            ©2011 MedPro Inc. All rights reserved. Terms of Use | Privacy Policy


Contact | Site Map





















Syndromic Infectious Disease Diagnostics | BioFire Diagnostics



























 











 













 MENU
                
  




HOME
PRODUCTS

Solutions

For Healthcare Providers
For Labs
For Customers


FilmArray

FilmArray® Link Software


Panels
Testimonials
Request a Demo


RESEARCH

For Payors


COMPANY

Mission & Values
Careers
Contact


MEDIA

Conferences & Events
Press Releases
Press Kit


SUPPORT

Video Library
FAQ
Continuing Education
Return Forms
Documents


 




Sign up for Updates

*



  










This iframe contains the logic required to handle AJAX powered Gravity Forms.

 




 

















 Syndromic Testing:
The Right Test, The First Time.
Rapidly identify infections with symptom-driven testing

For Healthcare ProvidersFor LabsFor Customers 







 
 



   FilmArray®
The Fastest Way to Better Results
The FilmArray System from BioFire is the new standard for syndromic infectious disease diagnostics. Simple, fast and comprehensive, the FilmArray delivers accurate results in about an hour. The right test, the first time can impact all areas of patient care. Healthcare providers can see faster diagnoses and improved antibiotic stewardship. Labs can see improved efficiency and reduced costs and downstream testing.
Read More


  




FilmArray ® Panels
The five, FDA-cleared FilmArray panels test for viruses, bacteria, parasites, yeast and antimicrobial resistance genes. Whether you’re trying to select appropriate therapy for a septic patient or determine exactly which respiratory pathogen is making a young child sick, the FilmArray® System can return answers fast.
Learn More
  




Respiratory


 




Blood Culture ID


 




Gastrointestinal


 




Meningitis


 





 BioFire Diagnostics
Leading the Way
With more than 25 years of molecular experience, BioFire Diagnostics, LLC sets the standard
for molecular diagnostics through its pioneering advances in syndromic infectious disease
testing.
As BioMérieux’s Global Center of Excellence for Molecular Diagnostics, no other company
has FDA-cleared and CE-IVD marked assays for more pathogens. BioFire Diagnostics has
produced the easiest, fastest and most comprehensive multiplex PCR system available: the
FilmArray.
LEARN MORE















Unique Values for Clinics, Labs and Customers
The combination of fast, easy and comprehensive is really powerful. These characteristics define the FilmArray® System. For clinics, labs and current customers, BioFire’s molecular diagnostic solutions provide unique value.
 







For Healthcare Providers
The BioFire FilmArray® helps healthcare providers improve patient care and satisfaction by providing faster and better results.
 Learn More 







For Labs
The BioFire FilmArray easily integrates into clinical laboratories, allowing for relevant molecular testing around the clock.
 Learn More 







For Customers
Easy access to information and resources to help current customers use BioFire products with confidence.
 Learn More 










Request a FilmArray Demo
Are you ready to order the FilmArray or want to request a free demo? Please fill out this form to take the next step towards faster results. Our team is ready to answer all of your questions.
Request a Demo
















































Enzymes













































Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more



OK








Close
Choose a BASF website




                        Asia Pacific







 




                        Americas







 




                        Europe







 




                        Middle East - Africa







 







BASF Global
Asia Pacific
Americas
Europe
Middle East - Africa










        Close
Select your language


BASF Global 
This page is available in the following languages:




                            English





 
		Close




					Logged in


					Error logging out







						Hello,
						you are logged in with access to additional information




 
									BASF ecommerce platform




								Logout










					Login


					Invalid Login Credentials






						Please login with your username and password




								Username






								Password










											Keep me Logged In









 
									Forgot your password?







					You want to purchase products or view order status from BASF SE?


 
						BASF ecommerce platform


					Would you like to register to get personalized information?

Register here
					to get additional information like specific downloads









				Register to BASF.com
			







					Registration is successful. Lorem ipsum doloramet, conseteture sadipscing.
				



						Registration is unsuccessful. Lorem ipsum doloramet consetetur.
					


							Back To Registration Form
						








							FirstName
						






							LastName
						






							Company
						






							Country
						

							
								Please choose your country.
							


									Please choose your country.
								





		Industry
	



                Please choose your industry.
            





							Sub Industry
						

Please choose sub-industry.


									Please choose sub-industry.
								





							Street, Number
						









							Postal Code, City
						









							Phone
						






							Email
						






							Desired Password
							







							Repeat Password
						









									BASF User Agreement
								









											Details BASF User Agreement
										





												BASF User Agreement
											









								Register
							







				You want to purchase products or view order status from BASF SE?
			



 
						BASF ecommerce platform
					










					Forgot your password?








						Please provide your registered Email ID to reset your password 


                        Reset Password Link has been sent to Provided Registration E-Mail ID.


                        Please provide a valid Registered E-Mail ID.





								Email









									Submit





























































Enzymes

Enzymes




Contact

























...


...



 BASF - We create chemistry - Home   
Products & Industries / Enzymes








Industrial Enzyme Solutions








BASF is a recognized pioneer in the development and commercialization of high-performance enzymes for use in industrial processes. BASF sells enzymes developed using its unique R&D capabilities to satisfy the needs of the global market. Leveraging its unique, patented technology, the company harnesses the power of nature and creates products that maximize efficiency while improving environmental performance.





















Global ChallengesThe global population is estimated to reach 9 billion by 2050. Major challenges to support that growth include having enough water, food and energy for all while meeting expectations of rising living standards. At BASF we believe through creating chemistry and leveraging industrial biotechnology, we will be able to meet these challenges.






 Markets we serve


























Why Enzymes?From enzymes in detergents, to enzymes which enhance the nutrition of the food we eat, enzymes are part of our everyday lives. They make the products we use daily more efficient, are naturally biodegradable and have a great safety profile. Enzymes are part of a growing movement towards the biobased economy.






 Why Enzymes?
























Innovate with UsWe invite potential collaborators and customers to engage with BASF to jointly collaborate and solve problems together.






 Work with us
























Our ScienceOur technology platform harnesses all of nature’s biodiversity, and brings that biodiversity to the commercial realm via enzyme products.






 What we do















Share


LinkedIn


Facebook


Twitter


Google+


Email



Print






























Ironwood Pharmaceuticals























Skip to main content








    You are now leaving ironwoodpharma.com.
  










    You are now leaving ironwoodpharma.com. This link will take you to
    a website to which our privacy policy does not apply. You are solely
    responsible for your interactions with that website.
  






 
  


  


THE ART AND SCIENCE OF MAKING MEDICINESWe’re focused on three goals: transforming knowledge into medicines that make a
difference for patients, creating value that will inspire the continued support of our
fellow shareholders, and building a team that passionately pursues excellence.






RECENT NEWS
07.20.17Ironwood Pharmaceuticals to Host Second Quarter 2017 Investor Update Call »07.20.17Ironwood Pharmaceuticals Reports Positive Top-line Results from IW-3718 Phase IIb Trial in Uncontrolled Gastroesophageal Reflux Disease »




In our analytical chemistry lab


INSIDE IRONWOOD
Building a Top-Performing Commercial Biotech Company
We are focusing on several
important franchises, including
IBS-C/CIC, refractory GERD,
uncontrolled gout, and vascular
and fibrotic diseases.
find out more »






Click here for full US Prescribing Information including BOXED WARNING »Learn more about LINZESS® »Click here for full US Prescribing Information including LIMITATIONS OF USE and BOXED WARNING »Learn more about ZURAMPIC® »



Members of our analytical pharmacology team






















Ironwood Pharmaceuticals
          301 Binney Street
          Cambridge, MA 02142
tel 617.621.7722
          fax 617.494.0480











ABOUT US
Overview
Core Values
Management Team
Founders
Board of Directors
Pharmaceutical  Advisory Committee
Contact Us
Transparency


Our MEDICINES
Overview
Discovery of Linaclotide
Global Strategy
 
R&D
Overview
Key Programs
Approach

 
COLLABORATE
Overview
Accessing Additional Products
Globalization


Investors
Overview
Business Principles
Events
Corp. Governance
Financial Information
Stock Information
Investor FAQ's
Press Releases
Investor Contacts


NEWS
Overview
Press Releases
Social Media
Multimedia
Resources


Join US
Overview
Career Openings
Sales Openings
Our Community
Our Expertise

 Copyright © 2017, Ironwood Pharmaceuticals, Inc. All Rights Reserved    |    Privacy Policy    |    Terms of Service   |    Site Design
LINZESS® is a registered trademark of Ironwood Pharmaceuticals, Inc., ZURAMPIC®, DUZALLO™  are registered trademarks of AstraZeneca AB Corporation or its affiliates and are used herein under license.





















Athyrium Capital Management | Athyrium Opportunities Fund (AOF)











 


Investor Login

AOF I Portal
AOF II Portal






   



Athyrium Opportunities Fund (AOF)




 






AOF II


AOF I
 
Previous Investments





Athyrium Opportunities Fund1


Company
Marketer / Counterparty
Product
Initial Investment Date


MedPro Safety Products
Greiner Bio-One
Vacuette Safety System
February 2012


BioFire Diagnostics
BioFire
FilmArray
September 2012


Verenium
Verenium
Various
December 2012


Ironwood Pharmaceuticals
Ironwood and Forest Laboratories
Linzess
January 2013


SynCardia Systems, Inc.
SynCardia
Total Artificial Heart
March 2013


Progenity, Inc.
Progenity, Inc.
Various Genetic Tests
June 2013


Tria Beauty, Inc.
Tria Beauty
Skincare Products
July 2013


InnoPharma, Inc.
Various Marketing Partners
Specialty Injectable and Ophthalmic Generic Pharmaceuticals
October 2013


Horizon Pharma, Inc.
Horizon Pharma
Various NSAIDs and ACTIMMUNE
November 2013


Universal Biosensors, Inc.
LifeScan (J&J) and Siemens
Point of Care (POC) Diagnostics
December 2013


Pernix Therapeutics Holdings, Inc.
Pernix
Treximet and Others
February 2014


Ikaria, Inc.
Ikaria
INOMAX
February 2014


VIVUS, Inc.
VIVUS, Inc.
Qsymia and STENDRA/SPEDRA
February 2014


Synarc-Biocore Holdings, LLC
Synarc-Biocore Holdings
Specialty Clinical Research Services
March 2014


Retrophin, Inc.
Alamo Pharma Services, Inc.
Chenodal / Thiola
July 2014


Tecomet, Inc.
Tecomet
Orthopedic and Other Contract Manufacturing Services
December 2014


Zealand Pharma A/S
Sanofi
Lyxumia
December 2014


Lannett Company, Inc.
Lannett Company, Inc.
Generic Pharmaceuticals
December 2015


1. This table lists all investments made by the Athyrium Opportunities Fund.







 
 

 














 













 




Athyrium Opportunities Fund III LP - Who is raising money? | SEC filings of fundraisings and investments in hedge funds, startups and private equity companies















Who is raising money?











Athyrium Opportunities Fund III LP  Funding details


Athyrium Opportunities Fund III LP Industry: Pooled Investment FundCIK Number: 0001690482Address: C/O ATHYRIUM CAPITAL MANAGEMENT, LP 530 FIFTH AVENUE, FLOOR 25 NEW YORK 10036Phone number: 212-402-6925



Latest news
Athyrium Opportunities Fund III LP raised $255,000,000 from 11 investors on 2016-11-30.



Athyrium Opportunities Fund III LP Filings

DateFiling TypeOfferedSoldRemainingMin. investmentInvest. countExemption / Exlusions
2016-11-30New Form DIndefinite$255,000,000Indefinite$01106b 3C 3C.7[SEC Filing]
Athyrium Opportunities Fund III LP raised $255,000,000 in total.



Directors and Executives of Athyrium Opportunities Fund III LP
Key People in Athyrium Opportunities Fund III LP:

ANDREW HYMANPAUL WAKEFIELDCOURTNEY PAULELIN STRONGJEFFREY FERRELLJEREMY LACK
Similar companiesAthyrium Partners, LP, Athyrium Opportunities Fund (B) LP, Athyrium Opportunities Fund II (Non-US) LP, Athyrium Opportunities Fund II LP, Athyrium Opportunities Fund II-B Master LP, Athyrium Opportunities Fund III (Non-US) A LP, Athyrium Opportunities Fund III (Non-US) B LP, Athyrium Healthcare Strategic Income & Growth IDF LLC








Last visited companies: Fast Pay Partners LLC, FireHost, Inc., TWELVE, Inc., GABELLI ASSOCIATES FUND, GABELLI ASSOCIATES FUND II L.P.

								© whoisraisingmoney.com
Daily updated news about investment into startups, hedge funds and private equity companies.



















Athyrium Opportunities Fund III (Non-US) B LP - Pooled Investment Fund- Ferrell  FormDs.com - SEC filings of fundraisings and investments in hedge funds, private equity firms, startups, and growing companies 











 FormDs.com 





 Newest
 Filter
 Local




 









Athyrium Opportunities Fund III (Non-US) B LP

      Industry: Pooled Investment Fund
      (See others in industry)

Address:



    C/O Athyrium Capital Management, Lp 530 Fifth Avenue, Floor 25 
    New York, NY, 10036Phone: 212-402-6925 




Filings



Date
FilingType
Reported Sold
Incremental Cash 
Type
Exemptions
Link to Raw Filing




	2016-11-30


New


$150,000,000


$150,000,000


Other


06b 3C 3C.7


SEC link






Directors and Executives (Current and Past)



Name
Role



 Jeffrey A. Ferrell 
 Executive 


 Andrew C. Hyman 
 Executive 


 Jeremy D. Lack 
 Executive 


 Courtney Paul 
 Executive 


 Elin Strong 
 Executive 


 Paul A. Wakefield 
 Executive 












Athyrium Opportunities Fund III (Non-US) B LP - List of CEOs, founders and company directors

















directorpedia.net - List of CEOs, founders, board members and company directors











Athyrium Opportunities Fund III (Non-US) B LP
List of persons related to the company Athyrium Opportunities Fund III (Non-US) B LP. Find out list of CEOs, founders, board members, and company directors of Athyrium Opportunities Fund III (Non-US) B LP.

CIK Number: 0001690480Company address: C/O ATHYRIUM CAPITAL MANAGEMENT, LP 530 FIFTH AVENUE, FLOOR 25 NEW YORK 10036Phone number: 212-402-6925



People related to Athyrium Opportunities Fund III (Non-US) B LP
NamePositionStreetCityCountryC. HYMAN  ANDREWC/O ATHYRIUM CAPITAL MANAGEMENT, LP 530 FIFTH AVENUE, FLOOR 25NEW YORKNYPAUL  COURTNEYC/O ATHYRIUM CAPITAL MANAGEMENT, LP 530 FIFTH AVENUE, FLOOR 25NEW YORKNYSTRONG  ELINC/O ATHYRIUM CAPITAL MANAGEMENT, LP 530 FIFTH AVENUE, FLOOR 25NEW YORKNYA. FERRELL  JEFFREYC/O ATHYRIUM CAPITAL MANAGEMENT, LP 530 FIFTH AVENUE, FLOOR 25NEW YORKNYD. LACK  JEREMYC/O ATHYRIUM CAPITAL MANAGEMENT, LP 530 FIFTH AVENUE, FLOOR 25NEW YORKNYA. WAKEFIELD  PAULC/O ATHYRIUM CAPITAL MANAGEMENT, LP 530 FIFTH AVENUE, FLOOR 25NEW YORKNY




Athyrium Opportunities Fund III (Non-US) B LP on the Web
Related companiesAthyrium Healthcare Strategic Income & Growth IDF LLC, Athyrium Opportunities Fund (B) LP, Athyrium Opportunities Fund II (Non-US) LP, Athyrium Opportunities Fund II LP, Athyrium Opportunities Fund II-B Master LP, Athyrium Opportunities Fund III (Non-US) A LP, Athyrium Opportunities Fund III LP, Athyrium Partners, LP












 








Athyrium Opportunities Fund III (Non-US) B LP - Who is raising money? | SEC filings of fundraisings and investments in hedge funds, startups and private equity companies















Who is raising money?











Athyrium Opportunities Fund III (Non-US) B LP  Funding details


Athyrium Opportunities Fund III (Non-US) B LP Industry: Pooled Investment FundCIK Number: 0001690480Address: C/O ATHYRIUM CAPITAL MANAGEMENT, LP 530 FIFTH AVENUE, FLOOR 25 NEW YORK 10036Phone number: 212-402-6925



Latest news
Athyrium Opportunities Fund III (Non-US) B LP raised $150,000,000 from 1 investor on 2016-11-30.



Athyrium Opportunities Fund III (Non-US) B LP Filings

DateFiling TypeOfferedSoldRemainingMin. investmentInvest. countExemption / Exlusions
2016-11-30New Form DIndefinite$150,000,000Indefinite$0106b 3C 3C.7[SEC Filing]
Athyrium Opportunities Fund III (Non-US) B LP raised $150,000,000 in total.



Directors and Executives of Athyrium Opportunities Fund III (Non-US) B LP
Key People in Athyrium Opportunities Fund III (Non-US) B LP:

ANDREW HYMANPAUL WAKEFIELDCOURTNEY PAULELIN STRONGJEFFREY FERRELLJEREMY LACK
Similar companiesAthyrium Partners, LP, Athyrium Opportunities Fund (B) LP, Athyrium Opportunities Fund II (Non-US) LP, Athyrium Opportunities Fund II LP, Athyrium Opportunities Fund II-B Master LP, Athyrium Opportunities Fund III (Non-US) A LP, Athyrium Opportunities Fund III LP, Athyrium Healthcare Strategic Income & Growth IDF LLC








Last visited companies: Shoreline Fund I, L.P., 137 Affiliates, LP, 3 Twelve Fund, LP, A.R.T. International Investors (USA) LLC, AERO-X GOLF, INC.

								© whoisraisingmoney.com
Daily updated news about investment into startups, hedge funds and private equity companies.
















Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version


















Waiver And Fourth Amendment To Amended And Restated Credit Agreement - Waiver Agreement - Free Search.
















 


















                 You are here: Agreements   > Waiver Agreement     > WAIVER AND FOURTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT

 
Search Documents | Browse Documents











SITE SEARCH


AGREEMENTS / CONTRACTS






Document Title:



Entire Document:(optional)



Governing Law(optional)

AllAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFlorida
                            GeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMaryland
                            MassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevada
                            New HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahoma
                            OregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtah
                            VermontVirginiaWashingtonWest VirginiaWisconsinWyoming 






Try our advanced search >>

CLAUSES
Search Contract Clauses >>
Browse Contract Clause Library>>

















Waiver And Fourth Amendment To Amended And Restated Credit Agreement
Waiver Agreement



You are currently viewing:
 This Waiver Agreement involves SYNCARDIA SYSTEMS INC | ATHYRIUM OPPORTUNITIES ASSOCIATES GP LLC | SWK FUNDING LLC | SWK Holdings Corporation | SynCardia Systems, Inc. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.  
                  



Title: WAIVER AND FOURTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT Governing Law: New York      Date: 8/17/2015 









Preview

Edit & Save 

Related Documents 



50 of the Top 250 law firms use our Products every day









Exhibit 10.21

WAIVER AND FOURTH AMENDMENT TO
AMENDED AND RESTATED CREDIT AGREEMENT

THIS WAIVER AND FOURTH AMENDMENT TO
AMENDED AND RESTATED CREDIT AGREEMENT (the “ Agreement
”) dated as of June 19, 2015 is entered into among
SynCardia Systems, Inc., a Delaware corporation (the “
Borrower ”), the Lenders party hereto and Cantor
Fitzgerald Securities, as Administrative Agent. All capitalized
terms used herein and not otherwise defined herein shall have the
meanings given to such terms in the Credit Agreement (as defined
below).

RECITALS

WHEREAS, the Borrower, the Lenders
and the Administrative Agent entered into that certain Amended and
Restated Credit Agreement dated as of December 13, 2013 (as
amended or modified from time to time, the “ Credit
Agreement ”);

WHEREAS, in reviewing the
Borrower’s books and records, the Borrower believes that it
may have failed to comply with certain terms and conditions of the
Credit Agreement as more fully set forth on Schedule A to
this Agreement, with any Defaults or Events of Default arising from
the failure to comply with the terms of the Credit Agreement,
exclusively to the extent set forth on Schedule A , being
referred to as the “ Acknowledged Events of Default
”);

WHEREAS, the Borrower has requested
that, and the Lenders have agreed to, waive the Acknowledged Events
of Default and amend certain provisions of the Credit Agreement as
more fully set forth herein; and

NOW, THEREFORE, in consideration of
the premises and the mutual covenants contained herein, and for
other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto agree as
follows:

1. Reaffirmation . The
Borrower acknowledges and reaffirms (a) that it is bound by
all of the terms of the Investment Documents to which it is a party
and (b) that it is responsible for the observance and full
performance of all Obligations, including without limitation, the
repayment of the Loans and interest and prepayment premiums thereon
and fees with respect thereto. Furthermore, the Borrower
acknowledges and confirms (x) that the Administrative Agent
and the Lenders have performed fully all of their respective
obligations under the Credit Agreement and the other Investment
Documents and (y) that by entering into this Agreement, the
Administrative Agent and the Lenders do not waive or release any
term or condition of the Credit Agreement or any of the other
Investment Documents or any of their rights or remedies under such
Investment Documents or any applicable law or any of the
obligations of the Loan Parties thereunder.

2. Amendments . The Credit
Agreement is hereby amended as follows:

(a) A new defined term “Add-On
Term Loan Warrants” is added to Section 1.01 of the
Credit Agreement in alphabetical order:

“ Add-On Term Loan
Warrants ” means those certain warrants issued to the
Add-On Term Loan Lenders in connection with the funding of the
Add-On Term Loans in the amounts set forth on Schedule
2.01.



(b) Clause (c)(ii) of the definition
of “Change of Control” in Section 1.01 of the
Credit Agreement is deleted in its entirety and amended to read as
follows:

(ii) Michael Garippa ceases to be
the chief executive officer of the Borrower; provided ,
that , any “Change of Control” arising solely
under this clause (c)(ii) shall not be triggered if a replacement
permanent chief executive officer of the Borrower reasonably
acceptable to the Required Lenders is named within three
(3) months of the date that Michael Garippa ceases to be the
chief executive officer of the Borrower or if Michael Garippa
ceases to be the chief executive officer of the Borrower after an
IPO is consummated.

(c) The defined term
“Warrants” is amended and restated in its entirety to
read as follows:

“ Warrants ”
means the Add-On Term Loan Warrants substantially in the form of
Exhibit B-5 and those certain Series E Convertible Preferred Stock
Purchase Warrants of the Borrower purchased by certain of the
Lenders, substantially in the form of Exhibit B-4 . The
Warrants shall have the respective rights set forth therein and
shall be in the respective amounts set forth on Schedule
2.01 .

(d) Section 2.03(e) of the
Credit Agreement is amended by adding the new subsection
(iii) which shall read as follows:

(iii) Prepayments of Add-On Term
Loans Before June 19, 2017 . If all or any portion of the
Add-On Term Loans are prepaid, or required to be prepaid, pursuant
to Section 2.03(b), Section 2.03(c) or Section 9.02
before June 19, 2017, the Borrower shall pay to the
Administrative Agent (for further distribution to the Lenders), for
the respective ratable accounts of the Add-On Term Lenders, on the
date on which such prepayment is paid or required to be paid, in
addition to the other Obligations so prepaid or required to be
prepaid, a prepayment premium in an amount equal to five percent
(5%) of the principal amount of the Add-On Term Loans prepaid
or required to be prepaid on such date.

(e) Section 7.01(a) of the
Credit Agreement is hereby amended to delete the following
clause:

“shall not be subject to any
‘going concern’ or like qualification or exception or,
for all such opinions, any qualification or exception as to the
scope of such audit”

And replace it with the following
language:

“shall (at all times prior to
consummation of an IPO) not be subject to any ‘going
concern’ or like qualification or exception or, for all such
opinions, any qualification or exception as to the scope of such
audit”

(f) Section 7.01(c) of the
Credit Agreement is hereby amended to delete the following
clause:

“, a balance sheet of the
Borrower and its Subsidiaries as at such fiscal quarter
end,”



(g) Section 7.03(g) of the
Credit Agreement is hereby amended and restated in its entirety to
read as follows:

(g) Notify the Administrative Agent
and each Lender, at least five (5) Business Days in advance,
of (i) the payment of any fees, expenses or other amounts
(other than, for the avoidance of doubt, payments under the
Investment Documents; payments under the Second Lien Loan
Documents; payments of fees, costs and expenses incurred in
connection with an IPO; and payments of amounts not in excess of
the amounts set forth in the budget delivered to the Administrative
Agent and the Lenders pursuant to Section 7.02(a)) by the
Borrower or any Subsidiary in an aggregate amount (including all
amounts with respect to the facts and circumstances underlying such
payment) in excess of $100,000 or (ii) the Borrower or any
Subsidiary becoming bound by any Contractual Obligation which
requires, or otherwise incurring any obligation to, make payments
in an aggregate amount in excess of $ 100,000 (other than, for the
avoidance of doubt, payments under the Investment Documents;
payments under the Second Lien Loan Documents; payments of fees,
costs and expenses incurred in connection with an IPO; and payments
of amounts not in excess of the amounts set forth in the budget
delivered to the Administrative Agent and the Lenders pursuant to
Section 7.02(a)).

(h) Schedule 2.01 is amended and
restated in its entirety in the form attached hereto as Schedule
B .

(i) Exhibit B-5 attached to this
Agreement as Schedule C is added to the Exhibits to the
Credit Agreement.

3. Consents and Waiver
.

A. The undersigned Lenders
(constituting Required Lenders) hereby consent to all of the
following actions by the Borrower:

(a) Trinity Note Amendment .
The Borrower’s amendment of that certain Promissory Note
dated April 1, 2013 (the “ Trinity Bridge Note
”) by and between the Borrower and Trinity SynCardia Bridge,
LLC, an Arizona limited liability company (“ Trinity
SynCardia Bridge ”), in the original principal amount of
$500,000 to provide, among other things, for a maturity date of
December 15, 2015.

(b) Trinity Amendment
Consideration . The Borrower paying to Trinity SynCardia Bridge
the sum of $20,000 and issuing a warrant to Trinity SynCardia
Bridge to purchase 35,971 shares of the Borrower’s common
stock for $1.39 per share, all in consideration for the amendment
of the Trinity Bridge Note (the “Trinity Amendment
Consideration”).

(c) Add-On Term Loan Warrants
. Notwithstanding the provisions of Section 2.02 (c)(vi) of
the Credit Agreement, the issuance of the Add-On Term Loan Warrants
to the Add-On Term Loan Lenders in partial consideration for the
making of the Add-On Term Loans in the amounts set forth on
Schedule 2.01.

B. The undersigned Lenders hereby
waive the Acknowledged Events of Default.

4. Release . As a material
part of the consideration for the Administrative Agent and the
Lenders entering into this Agreement, the Borrower agrees as
follows (the “ Release Provision ”):



(a) By its signature below, the
Borrower hereby agrees that the Administrative Agent, the Lenders,
each of their respective Affiliates and each of the foregoing
Persons’ respective officers, managers, members, directors,
partners, agents and employees, and their respective successors and
assigns (hereinafter all of the above collectively referred to as
the “ Lender Group ”), are irrevocably and
unconditionally released, discharged and acquitted from any and all
actions, causes of action, claims, demands, damages and liabilities
of whatever kind or nature, in law or in equity, now known or
unknown, suspected or unsuspected to the extent that any of the
foregoing arises from any action or failure to act under or
otherwise arising in connection with the Investment Documents on or
prior to the date hereof.

(b) The Borrower hereby
acknowledges, represents and warrants to the Lender Group
that:

(i) The Borrower has read and
understands the effect of the Release Provision. The Borrower has
had the assistance of independent counsel of its own choice, or has
had the opportunity to retain such independent counsel, in
reviewing, discussing, and considering all the terms of the Release
Provision; and if counsel was retained, counsel for the Borrower
has read and considered the Release Provision and advised the
Borrower with respect to the same. Before execution of this
Agreement, the Borrower has had adequate opportunity to make
whatever investigation or inquiry it may deem necessary or
desirable in connection with the subject matter of the Release
Provision.

(ii) The Borrower is not acting in
reliance on any representation, understanding, or agreement not
expressly set forth herein. The Borrower acknowledges that the
Lender Group has not made any representation with respect to the
Release Provision except as expressly set forth herein.

(iii) The Borrower has executed this
Agreement and the Release Provision thereof as its free and
voluntary act, without any duress, coercion, or undue influence
exerted by or on behalf of any person.

(iv) The Borrower is the sole owner
of the claims released by the Release Provision, and the Borrower
has not heretofore conveyed or assigned any interest in any such
claims to any other Person.

(c) The Borrower understands that
the Release Provision was a material consideration in the agreement
of the Administrative Agent and the Lenders to enter into this
Agreement. The Release Provision shall be in addition to any
rights, privileges and immunities granted to the Administrative
Agent and the Lenders under the Investment Documents.

5. Conditions Precedent .
This Agreement shall be effective upon satisfaction of the
following conditions precedent (such date, the “ Fourth
Amendment Effective Date ”):

(a) the receipt by the
Administrative Agent of counterparts of this Agreement duly
executed by the Borrower and the Lenders and acknowledged by the
Administrative Agent;

(b) the receipt by each Add-On Term
Loan Lender of an electronic copy of a fully executed promissory
note for such Add-On Term Loan Lender’s respective Add-On
Term Loan (such notes, collectively the “ Add-On Term Loan
Notes ”);

(c) payment, by the Borrower, of an
amendment fee of one percent (1%) of the outstanding principal
amount of the Add-On Term Loans funded in connection with
this



Agreement, directly to each Add-On
Term Loan Lender on a pro rata basis based on their respective
shares of the Add-On Term Loans;

(d) payment, by the Borrower, of all
outstanding fees, costs and expenses of counsel to the Lenders and
the Administrative Agent incurred in drafting, negotiating and
consummating the transactions contemplated by this Agreement or
currently outstanding under the Investment Documents;

(e) the Administrative Agent shall
have received a certificate of a Responsible Officer of the
Borrower, in form and substance reasonably satisfactory to the
Lenders, (i) certifying that the Organization Documents of the
Borrower delivered on the Fourth Amendment Effective Date have not
been amended, supplemented or otherwise modified and remain in full
force and effect as of the Fourth Amendment Effective Date;
(ii) attaching resolutions of the Borrower approving and
adopting this Agreement, the transactions contemplated herein and
authorizing the execution and delivery of this Agreement and any
documents, agreements or certificates related thereto and
certifying that such resolutions have not been amended,
supplemented or otherwise modified and remain in full force and
effect as of the Fourth Amendment Effective Date and
(iii) certifying that after the waiver of the Acknowledged
Events of Default, no Default or Event of Default shall have
occurred or be continuing;

(f) Cooley LLP, counsel to the
Borrower, shall have delivered to the Administrative Agent a
customary legal opinion that is reasonably satisfactory to each
Lender and the Administrative Agent; and

(g) the execution and delivery of an
Add-On Term Loan Joinder Agreement by the Lenders party thereto and
the Borrower, in a form acceptable to the Administrative Agent and
the Required Lenders, and the receipt by the Borrower of the
proceeds of Add-On Term Loans with a face principal amount of no
less than $6,000,000.

6. Miscellaneous .

(a) The Credit Agreement, as
modified hereby, and the obligations of the Loan Parties thereunder
and under the other Investment Documents, are hereby ratified and
confirmed and shall remain in full force and effect according to
their terms. This Agreement shall constitute a Loan
Document.

(b) The Borrower hereby represents
and warrants as follows:

(i) it has taken all necessary
action to authorize the execution, delivery and performance of this
Agreement;

(ii) this Agreement has been duly
executed and delivered by the Borrower and constitutes the
Borrower’s legal, valid and binding obligation, enforceable
in accordance with its terms, except as such enforceability may be
subject to (A) bankruptcy, insolvency, reorganization,
fraudulent conveyance or transfer, moratorium or similar laws
affecting creditors’ rights generally and (B) general
principles of equity (regardless of whether such enforceability is
considered in a proceeding at law or in equity); and

(iii) no consent, approval,
authorization or order of, or filing, registration or qualification
with, any court or governmental authority or third party is
required in



connection with the execution,
delivery or performance by the Borrower of this
Agreement

(c) The Borrower represents and
warrants to the Administrative Agent and the Lenders that, after
giving effect to this Agreement, (i) the representations and
warranties of the Loan Parties set forth in Article VI of
the Credit Agreement and in each other Investment Document are true
and correct in all material respects (or, if any such
representation or warranty is qualified by materiality or Material
Adverse Effect, it shall be true and correct in all respects) as of
the date hereof with the same effect as if made on and as of the
date hereof, except to the extent such representations and
warranties expressly relate solely to an earlier date and
(ii) no event has occurred and is continuing which constitutes
(A) a Default or an Event of Default or (B) an Event of
Non-Compliance under the Warrants.

(d) This Agreement may be executed
in any number of counterparts, each of which when so executed and
delivered shall be an original, but all of which shall constitute
one and the same instrument. Delivery of an executed counterpart of
this Agreement by telecopy shall be effective as an original and
shall constitute a representation that an executed original shall
be delivered.

(e) THIS AGREEMENT AND THE RIGHTS
AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY AND
CONSTRUED AND INTERPRETED IN ACCORDANCE WITH THE LAWS OF THE STATE
OF NEW YORK.

(f) Direction . The Lenders
party hereto (constituting Required Lenders) hereby direct and
authorize the Administrative Agent, pursuant to Section 10.03
of the Credit Agreement, to execute and deliver the Agreement and
the Add-On Term Loan Joinder Agreement (the foregoing, the “
Direction ”). The Lenders party hereto acknowledge and
affirm their obligations under Section 10.03 of the Credit
Agreement to hold harmless and indemnify the Administrative Agent
in connection with the Direction. The Lenders party hereto,
constituting each existing Lender, acknowledge and agree that they
have been afforded the opportunity to commit to the Add-On Term
Loan in an amount equal to its Applicable Percentage of all of the
outstanding Loans as of the Restatement Date.

(g) Delivery of Add-On Term Loan
Notes . Within two Business Days of the Fourth Amendment
Effective Date, the Borrower shall deliver originals of the Add-On
Term Loan Notes to the applicable Add-On Term Loan
Lenders.

[Signature pages follow]



IN WITNESS WHEREOF , the
parties hereto have caused this Agreement to be duly executed as of
the date first above written.
 












BORROWER:


 



 


SYNCARDIA
SYSTEMS, INC.,





 



 


a Delaware
corporation











 



 


By:


 




/s/ Michael Garippa






 



 


Name:


 


Michael
Garippa





 



 


Title:


 


Chief Executive
Officer



 
[Fourth Amendment to Syncardia A&R Credit
Agreement]




















LENDERS:


 



 


ATHYRIUM
OPPORTUNITIES FUND (A) LP,





 



 


a Delaware
limited partnership











 



 



 


By: ATHYRIUM
OPPORTUNITIES ASSOCIATES LP, its General Partner












 



 



 



 


By: ATHYRIUM
OPPORTUNITIES ASSOCIATES GP LLC, the General Partner of Athyrium
Opportunities Associates LP














 



 



 



 



 


By:


 




/s/ Andrew Hyman






 



 



 



 



 


Title:


 




Authorized Signatory






 



 



 



 



 


Date:


 




 












 



 


ATHYRIUM OPPORTUNITIES FUND (B) LP,

a Delaware limited
partnership











 



 



 


By: ATHYRIUM
OPPORTUNITIES ASSOCIATES LP, its General Partner












 



 



 



 


By: ATHYRIUM
OPPORTUNITIES ASSOCIATES GP LLC, the General Partner of Athyrium
Opportunities Associates LP














 



 



 



 



 


By:


 




/s/ Andrew Hyman






 



 



 



 



 


Title:


 




Authorized Signatory






 



 



 



 



 


Date:


 




 












 



 


SWK FUNDING LLC,

a Delaware limited liability
company












 



 



 


By:


 


SWK Holdings
Corporation, its sole Manager















 








 


















Waiver Agreement, Waiver Contracts - Free Legal Documents (page 1 Of 60)

















 


















                 You are here: Agreements   > Waiver Agreement    

 
Search Documents | Browse Documents













SITE SEARCH


AGREEMENTS / CONTRACTS






Document Title:



Entire Document:(optional)



Governing Law(optional)

AllAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFlorida
                            GeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMaryland
                            MassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevada
                            New HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahoma
                            OregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtah
                            VermontVirginiaWashingtonWest VirginiaWisconsinWyoming 






Try our advanced search >>

CLAUSES
Search Contract Clauses >>
Browse Contract Clause Library>>








Waiver Agreements 





	These Waiver Agreements are actual legal documents drafted by top law firms for their clients. Use them for competitive intelligence, drafting documents or to get information about transactions within a particular industry or sector. We have millions of legal documents and clauses that you can search for free.	



1) BlackRock Capital Investment Corporation Reports Financial Results for the Quarter and Year Ended December 31, 2016, Declares First Quarter 2017 Distribution of $0.18 per Share, and Announces Waiver of Incentive Fees based on IncomeParties: BLACKROCK CAPITAL INVESTMENT CORP | BlackRock Capital Investment Corporation Reports Financial 
								
								Document Date: 3/8/2017

2) HAIN CELESTIAL RECEIVES LENDER WAIVER AND EXTENSION OF CREDIT FACILITYParties: HAIN CELESTIAL GROUP INC | Hain Celestial Group, Inc 
								
								Document Date: 3/3/2017

3) NII HOLDINGS ANNOUNCES AMENDMENTS TO CREDIT AGREEMENTS AND RECEIPT OF BANK COVENANT WAIVERS IN BRAZILParties: NII HOLDINGS INC | NII Holdings, Inc 
								
								Document Date: 3/1/2017

4) CHANGE OF CONTROL WAIVERParties: UNION BANKSHARES CORP | StellarOne Bank | StellarOne Corporation | Union First Market Bankshares Corporation 
								
								Document Date: 2/28/2017
								
								
								Governing Law:Virginia
5) THIRTEENTH AMENDMENT TO CREDIT AGREEMENT AND SEVENTH AMENDMENT TO LIMITED WAIVER AGREEMENTParties: GLOBAL POWER EQUIPMENT GROUP INC. | BRADEN CONSTRUCTION SERVICES, INC | BRADEN HOLDINGS, LLC | BRADEN MANUFACTURING, LLC | CONSTRUCTION  MAINTENANCE PROFESSIONALS, LLC | GLOBAL POWER EQUIPMENT GROUP INC | GLOBAL POWER PROFESSIONAL SERVICES INC | GLOBAL POWER TECHNICAL SERVICES, INC | GPEG, LLC | JPMORGAN CHASE BANK, NA | KOONTZ-WAGNER CUSTOM CONTROLS HOLDINGS LLC | STEAM ENTERPRISES LLC | WELLS FARGO BANK, NATIONAL ASSOCIATION | WILLIAMS GLOBAL SERVICES, INC | WILLIAMS INDUSTRIAL SERVICES GROUP | WILLIAMS INDUSTRIAL SERVICES, LLC | WILLIAMS PLANT SERVICES, LLC | WILLIAMS SPECIALTY SERVICES, LLC 
								
								Document Date: 2/27/2017
								
								
								Governing Law:New York
6) CONSENT AND WAIVER AGREEMENTParties: SEVION THERAPEUTICS, INC. | Laidlaw  Company (UK) Ltd | Sevion Therapeutics, Inc 
								
								Document Date: 2/22/2017
								
								
								Governing Law:New York
7) WAIVER OF CLAIMS, GENERAL RELEASE AND NON-SOLICITATION AGREEMENTParties: GLOBAL EAGLE ENTERTAINMENT INC. | Global Eagle Entertainment Inc 
								
								Document Date: 2/21/2017

8) WAIVER OF CLAIMS AND GENERAL RELEASE AGREEMENTParties: GLOBAL EAGLE ENTERTAINMENT INC. | Global Eagle Entertainment Inc 
								
								Document Date: 2/21/2017

9) SECOND OMNIBUS AMENDMENT AND WAIVERParties: SABINE PASS LIQUEFACTION, LLC | ABN AMRO CAPITAL USA LLC | Accounts Bank | BANCO SANTANDER BANK, SA | BANK OF AMERICA, N.A. | Bank of Nova Scotia | BANK OF TOKYO-MITSUBISHI UFJ, LTD. | Commercial Bank Lender, Senior Issuing Bank | Common Security Trustee and Compass Bank | COMMONWEALTH BANK OF AUSTRALIA | CR�DIT AGRICOLE CORPORATE AND INVESTMENT BANK | CREDIT SUISSE AG | EXPORT-IMPORT BANK OF KOREA | Genera Manager Shinhan Bank | GOLDMAN SACHS BANK | HSBC BANK USA, NATIONAL ASSOCIATION | INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED, NEW YORK BANK | ING CAPITAL LLC | JP MORGAN CHASE BANK, NA | Korea Development Bank | MIZUHO BANK, LTD | MORGAN STANLEY BANK, NA | ROYAL BANK OF CANADA | SANTANDER BANK, NA | Secured Debt Holder Group | SUMITOMO MITSUI BANKING CORPORATION 
								
								Document Date: 2/3/2017
								
								
								Governing Law:New York
10) EXHIBIT 4.2 TWENTY-THIRD RESOLUTION Delegation of authority granted to the Board of Directors to increase the share capital under the conditions provided in Articles L. 3332-18 and following the French Labor Code, which entails shareholders' waiver of their preemptive right to subscribe the sharesParties: TOTAL S.A. 
								
								Document Date: 1/27/2017

11) THIRD AMENDMENT AND WAIVER TO CREDIT AGREEMENTParties: INTERNAP CORP | INTERNAP CONNECTIVITY LLC | Internap Corporation | Internap Network Services Corporation | Jefferies Finance LLC | UBERSMITH, INC 
								
								Document Date: 1/26/2017
								
								
								Governing Law:New York
12) TENTH AMENDMENT, CONSENT AND WAIVERParties: GEE GROUP INC. | ACCESS DATA CONSULTING CORPORATION | ACF FINCO I LP | BUSINESS MANAGEMENT PERSONNEL, INC, BMPS, INC, BMCH, INC, BMCHPA, INC | GEE GROUP INC (FORMERLY GENERAL EMPLOYMENT ENTERPRISES, INC), TRIAD PERSONNEL SERVICES, INC | PALADIN CONSULTING, INC | TRIAD LOGISTICS, INC, SCRIBE SOLUTIONS, INC, AGILE RESOURCES, INC 
								
								Document Date: 1/25/2017
								
								
								Governing Law:New York
13) WAIVERParties: HERON THERAPEUTICS, INC. /DE/ | AP Pharma, Inc | Baker Brothers Life Sciences, LP | Heron Therapeutics, Inc | Heron, TCP, Baker Bros Investments II, LP | Tang Capital Management, LLC | Tang Capital Partners, LP 
								
								Document Date: 1/24/2017

14) LETTER WAIVERParties: AUTODESK INC 
								Law Firm: Shearman Sterling
								Document Date: 1/19/2017
								
								
								Governing Law:New York
15) AZURE MIDSTREAM PARTNERS, LP LIMITED DURATION WAIVER AGREEMENTParties: AZURE MIDSTREAM PARTNERS, LP | Section 915 Financial | Wells Fargo Bank, National Association 
								
								Document Date: 1/18/2017
								
								
								Governing Law:New York
16) ACKNOWLEDGEMENT, CONSENT AND WAIVER AGREEMENTParties: COMSTOCK MINING INC. | Comstock Mining Inc | DWC Resources Inc | InterGroup Corporation | Northern Comstock LLC | Portsmouth Square, Inc | Santa Fe Financial Corporation 
								
								Document Date: 1/17/2017
								
								
								Governing Law:New York
17) THIRD AMENDMENT TO LIMITED WAIVERParties: MEMORIAL PRODUCTION PARTNERS LP | Administrative Agent, Issuing Bank | ASSOCIATED BANK, NA | BANK OF AMERICA, N.A. | BETA OPERATING COMPANY, LLC | BMO HARRIS BANK, NA | BRANCH BANKING AND TRUST COMPANY | CADENCE BANK, NA | CANADIAN IMPERIAL BANK OF COMMERCE, NEW YORK BRANCH | CAPITAL ONE, NATIONAL ASSOCIATION | CARGILL, INCORPORATED | CITIBANK, NA | CITIZENS BANK, NA | COLUMBUS ENERGY, LLC | COMERICA BANK | COMPASS BANK | CREDIT AGRICOLE CORPORATE AND INVESTMENT BANK | DEUTSCHE BANK AG | GOLDMAN SACHS BANK | ING CAPITAL LLC | JPMORGAN CHASE BANK, NA | MEMORIAL ENERGY SERVICES LLC | MEMORIAL MIDSTREAM LLC | MEMORIAL PRODUCTION FINANCE CORPORATION | Memorial Production Operating LLC | Memorial Production Partners GP LLC | MEMP SERVICES LLC | Original Limited | REGIONS BANK | RISE ENERGY BETA, LLC | RISE ENERGY MINERALS, LLC | Rise Energy Operating, LLC | ROYAL BANK OF CANADA | SAN PEDRO BAY PIPELINE COMPANY | SANTANDER BANK, NA | SUNTRUST BANK | UBS AG | US BANK NATIONAL ASSOCIATION | Wells Fargo Bank, National Association | WHT CARTHAGE LLC | WHT ENERGY PARTNERS LLC | ZB, NA DBA AMEGY BANK 
								Law Firm: Vinson Elkins
								Document Date: 1/17/2017
								
								
								Governing Law:New York
18) SIXTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT AND WAIVERParties: ROYAL HAWAIIAN ORCHARDS, L.P. | Royal Hawaiian Macadamia Nut, Inc | Royal Hawaiian Resources, Inc | Royal Hawaiian Services, LLC 
								
								Document Date: 1/13/2017
								
								
								Governing Law:California
19) WAIVER AND FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENTParties: VIVEVE MEDICAL, INC. | VIVEVE MEDICAL, INC | VIVEVE, INC | WESTERN ALLIANCE BANK 
								
								Document Date: 1/13/2017

20) SECOND AMENDMENT TO CREDIT AGREEMENT AND WAIVERParties: ROYAL HAWAIIAN ORCHARDS, L.P. | Royal Hawaiian Orchards, LP | Royal Hawaiian Resources, Inc 
								
								Document Date: 1/13/2017
								
								
								Governing Law:California
21) WAIVERParties: GREAT BASIN SCIENTIFIC, INC. | Great Basin Scientific, Inc 
								Law Firm: Schulte Roth
								Document Date: 1/9/2017
								
								
								Governing Law:New York
22) WaiverParties: GREAT BASIN SCIENTIFIC, INC. | Great Basin Scientific, Inc 
								Law Firm: Schulte Roth
								Document Date: 1/9/2017
								
								
								Governing Law:New York
23) WAIVER AND CONSENT January 5, 2017Parties: FOUNDATION MEDICINE, INC. | Foundation Medicine, Inc | Investor Group | Roche Holdings, Inc 
								
								Document Date: 1/6/2017
								
								
								Governing Law:Delaware
24) WAIVER AND FIFTH AMENDMENT TO THIRD AMENDED AND RESTATED REVOLVING CREDIT AGREEMENTParties: SOUTHCROSS ENERGY PARTNERS, L.P. | ABN AMRO CAPITAL USA LLC | Administrative Agent, Issuing Bank | BANK OF AMERICA, N.A. | Banking Products Services | CADENCE BANK | FL RICH GAS SERVICES GP, LLC | FL Rich Gas Utility GP, LLC | JPMORGAN CHASE BANK, NA | MIDFIRST BANK | RAYMOND JAMES BANK, NA | REGIONS BANK | ROYAL BANK of CANADA | SOUTHCROSS ALABAMA PIPELINE LLC | SOUTHCROSS CCNG GATHERING LTD | SOUTHCROSS CCNG TRANSMISSION LTD | SOUTHCROSS DELTA PIPELINE LLC | SOUTHCROSS ENERGY FINANCE CORP | SOUTHCROSS ENERGY GP LLC | SOUTHCROSS ENERGY LP LLC | SOUTHCROSS ENERGY OPERATING, LLC | Southcross Energy Partners GP, LLC | SOUTHCROSS ENERGY PARTNERS, LP | SOUTHCROSS GATHERING LTD | SOUTHCROSS GULF COAST TRANSMISSION LTD | SOUTHCROSS MARKETING COMPANY LTD | SOUTHCROSS NGL PIPELINE LTD | SOUTHCROSS NUECES PIPELINES LLC | SOUTHCROSS PROCESSING LLC | UBS AG | WELLS FARGO BANK, NA 
								Law Firm: Vinson Elkins;Latham Watkins
								Document Date: 1/3/2017
								
								
								Governing Law:New York
25) WAIVERParties: RUBY TUESDAY INC | Bank of America, N.A. | Ruby Tuesday, Inc 
								
								Document Date: 1/3/2017
								
								
								Governing Law:Georgia
26) FIRST AMENDMENT TO WAIVER AGREEMENTParties: RUBY TUESDAY INC | FIRST TENNESSEE BANK, NA | RUBY TUESDAY, INC 
								
								Document Date: 1/3/2017

27) LIMITED WAIVER AND SECOND AMENDMENT TO LOAN AGREEMENTParties: AMERIS BANCORP 
								
								Document Date: 12/29/2016
								
								
								Governing Law:Texas
28) AMENDMENT AND WAIVERParties: HPIL HOLDING | Kodiak Capital Group, LLC 
								
								Document Date: 12/27/2016

29) AMENDMENT OF THE EXECUTIVE EMPLOYMENT AGREEMENT AND WAIVERParties: CARDINAL FINANCIAL CORP | Cardinal Financial Corporation | UBV Holding Company, LLC | United Bankshares, Inc 
								
								Document Date: 12/22/2016

30) CONSENT AND WAIVER AGREEMENTParties: APOLLO MEDICAL HOLDINGS, INC. | Apollo Medical Holdings, Inc | Network Medical Management, Inc | Parent and Apollo Acquisition Corp 
								
								Document Date: 12/22/2016

31) WAIVER AGREEMENTParties: KLR ENERGY ACQUISITION CORP. | KLR Energy Acquisition Corp | KLR Energy Sponsor, LLC | KLR Group Investments, LLC | Rosehill Operating Company, LLC | Tema Oil and Gas Company 
								
								Document Date: 12/20/2016
								
								
								Governing Law:Delaware
32) AZURE MIDSTREAM PARTNERS, LP LIMITED DURATION WAIVER AGREEMENTParties: AZURE MIDSTREAM PARTNERS, LP | Section 915 Financial | Wells Fargo Bank, National Association 
								
								Document Date: 12/20/2016
								
								
								Governing Law:New York
33) HAIN CELESTIAL RECEIVES LENDER LIMITED WAIVER AND EXTENSION OF CREDIT FACILITYParties: HAIN CELESTIAL GROUP INC | Hain Celestial Group, Inc | HAIN CELESTIAL RECEIVES LENDER LIMITED | Nasdaq Stock Market LLC 
								
								Document Date: 12/20/2016

34) SECOND AMENDMENT TO LIMITED WAIVERParties: MEMORIAL PRODUCTION PARTNERS LP | Administrative Agent, Issuing Bank | ASSOCIATED BANK, NA | BANK OF AMERICA, N.A. | BETA OPERATING COMPANY, LLC | BMO HARRIS BANK, NA | BRANCH BANKING AND TRUST COMPANY | CADENCE BANK, NA | CANADIAN IMPERIAL BANK OF COMMERCE | CAPITAL ONE, NATIONAL ASSOCIATION | CARGILL, INCORPORATED | CITIBANK, NA | CITIZENS BANK, NA | COLUMBUS ENERGY, LLC | COMERICA BANK | COMPASS BANK | DEUTSCHE BANK AG | GOLDMAN SACHS BANK | ING CAPITAL LLC | INVESTMENT BANK | JPMORGAN CHASE BANK, NA | MEMORIAL ENERGY SERVICES LLC | MEMORIAL MIDSTREAM LLC | MEMORIAL PRODUCTION FINANCE CORPORATION | Memorial Production Operating LLC | Memorial Production Partners GP LLC | MEMP SERVICES LLC | Original Limited | REGIONS BANK | RISE ENERGY BETA, LLC | RISE ENERGY MINERALS, LLC | Rise Energy Operating, LLC | ROYAL BANK OF CANADA | SAN PEDRO BAY PIPELINE COMPANY | SANTANDER BANK, NA | SUNTRUST BANK | UBS AG | US BANK NATIONAL ASSOCIATION | Wells Fargo Bank, National Association | WHT CARTHAGE LLC | WHT Energy Partners LLC | ZB, NA DBA AMEGY BANK 
								Law Firm: Vinson Elkins
								Document Date: 12/19/2016
								
								
								Governing Law:New York
35) INSTRUMENT CONTAINS AN AFFIDAVIT OF CONFESSION OF JUDGMENT PROVISION WHICH CONSTITUTES A WAIVER OF IMPORTANT RIGHTS BORROWER MAY HAVE AND ALLOWS THE HOLDER TO OBTAIN A JUDGMENT AGAINST BORROWER WITHOUT ANY FURTHER NOTICEParties: INDOOR HARVEST CORP | FirstFire Global Opportunities Fund LLC 
								
								Document Date: 12/16/2016
								
								
								Governing Law:New York
36) WAIVER AND THIRD AMENDMENT TO CREDIT AGREEMENTParties: HARTE HANKS INC | 3Q DIGITAL, INC | HARTE HANKS DIRECT MARKETING/BALTIMORE, INC | HARTE HANKS, INC | HARTE-HANKS DATA SERVICES LLC | HARTE-HANKS DIRECT MARKETING/DALLAS, INC | HARTE-HANKS DIRECT MARKETING/FULLERTON, INC | HARTE-HANKS DIRECT MARKETING/JACKSONVILLE, LLC | HARTE-HANKS DIRECT MARKETING/KANSAS CITY, LLC | HARTE-HANKS DIRECT, INC | HARTE-HANKS LOGISTICS, LLC | HARTE-HANKS RESPONSE MANAGEMENT/AUSTIN, INC | HARTE-HANKS RESPONSE MANAGEMENT/BOSTON, INC | HARTE-HANKS STRATEGIC MARKETING, INC | LBC III KB FUNDING, LLC | LBC III WF FUNDING, LLC | NSO, INC | SALES SUPPORT SERVICES, INC | TRILLIUM SOFTWARE, INC | WELLS FARGO BANK, NATIONAL ASSOCIATION 
								
								Document Date: 12/16/2016
								
								
								Governing Law:Illinois
37) WAIVER AND AMENDMENT TO REVOLVING CREDIT FACILITYParties: FREQUENCY ELECTRONICS INC | 11 Volvo Drive, Rockleigh, New Jersey 07647, FEI COMMUNICATIONS, INC | 55 Charles Lindbergh Boulevard, Uniondale, New York 11553, FEI GOVERNMENT SYSTEMS, INC | FEI-ELCOM TECH, INC | FREQUENCY ELECTRONICS, INC | JPMORGAN CHASE BANK, NA | President, FEI-Zyfer, Inc 
								Law Firm: Greenberg Traurig
								Document Date: 12/16/2016
								
								
								Governing Law:New York
38) AGREEMENT AND WAIVER OF CLAIMSParties: ATT INC. | Mobility Services LLC 
								
								Document Date: 12/16/2016
								
								
								Governing Law:Texas
39) FOURTH QUARTER 2016 CONDITIONAL INCOME INCENTIVE FEE WAIVER AGREEMENTParties: HMS INCOME FUND, INC. | HMS ADVISER GP, LLC | HMS Adviser LP | HMS Adviser, Main Street Capital Partners, LLC | HMS Income Fund, Inc | Main Street Capital Corporation | MSC Adviser I, LLC 
								
								Document Date: 12/14/2016
								
								
								Governing Law:Texas
40) WAIVER AND CONSENT TO CREDIT AGREEMENTParties: DYNEGY INC. | BLACK MOUNTAIN COGEN, INC | BLUE RIDGE GENERATION LLC | CASCO BAY ENERGY COMPANY, LLC | Credit Suisse AG | DIGHTON POWER, LLC | DYNEGY ADMINISTRATIVE SERVICES COMPANY | DYNEGY COAL GENERATION, LLC | DYNEGY COAL HOLDCO, LLC | DYNEGY COAL INVESTMENTS HOLDINGS, LLC | DYNEGY COAL TRADING  TRANSPORTATION, LLC | DYNEGY COMMERCIAL ASSET MANAGEMENT, LLC | DYNEGY CONESVILLE, LLC | DYNEGY DICKS CREEK, LLC | DYNEGY ENERGY SERVICES (EAST), LLC | DYNEGY ENERGY SERVICES, LLC | DYNEGY EQUIPMENT, LLC | DYNEGY FAYETTE II, LLC | DYNEGY GAS GENERATION, LLC | DYNEGY GAS HOLDCO, LLC | DYNEGY GAS IMPORTS, LLC | DYNEGY GAS INVESTMENTS HOLDINGS, LLC | DYNEGY GAS INVESTMENTS, LLC | DYNEGY GASCO HOLDINGS, LLC | DYNEGY GENERATION HOLDCO, LLC | DYNEGY GLOBAL LIQUIDS, INC | DYNEGY HANGING ROCK II, LLC | Dynegy Inc | DYNEGY KENDALL ENERGY, LLC | DYNEGY KILLEN, LLC | DYNEGY LEE II, LLC | DYNEGY MARKETING AND TRADE, LLC | DYNEGY MIAMI FORT, LLC | DYNEGY MIDWEST GENERATION, LLC | DYNEGY MORRO BAY, LLC | DYNEGY MOSS LANDING, LLC | DYNEGY OAKLAND, LLC | DYNEGY OPERATING COMPANY | DYNEGY POWER GENERATION INC 
								
								Document Date: 12/14/2016
								
								
								Governing Law:New York
41) WAIVER AND FOURTH AMENDMENT TO THIRD AMENDED AND RESTATED REVOLVING CREDIT AGREEMENTParties: SOUTHCROSS ENERGY PARTNERS, L.P. | Administrative Agent, Issuing Bank | Banking Products Services | FL RICH GAS SERVICES GP, LLC | FL RICH GAS UTILITY GP, LLC | JPMorgan Chase Bank, NA | MidFirst Bank | Raymond James Bank, NA | Regions Bank | ROYAL BANK of CANADA | SOUTHCROSS ALABAMA PIPELINE LLC | SOUTHCROSS CCNG GATHERING LTD | SOUTHCROSS CCNG TRANSMISSION LTD | SOUTHCROSS DELTA PIPELINE LLC | SOUTHCROSS ENERGY FINANCE CORP | Southcross Energy GP LLC | SOUTHCROSS ENERGY LP LLC | SOUTHCROSS ENERGY OPERATING, LLC | Southcross Energy Partners GP, LLC | SOUTHCROSS ENERGY PARTNERS, LP | SOUTHCROSS GATHERING LTD | SOUTHCROSS MARKETING COMPANY | SOUTHCROSS NGL PIPELINE LTD | SOUTHCROSS NUECES PIPELINES LLC | SOUTHCROSS PROCESSING LLC | UBS AG | WELLS FARGO BANK, NA 
								
								Document Date: 12/12/2016
								
								
								Governing Law:New York
42) FIFTH AMENDMENT, CONSENT AND WAIVER TO CREDIT AGREEMENTParties: ARCHROCK, INC. | Archrock Services, LP | Archrock, Inc | BANK OF AMERICA, N.A. | BANK OF NOVA SCOTIA | BRANCH BANKING AND TRUST COMPANY | CAPITAL ONE, NATIONAL ASSOCIATION | CITIBANK, NA | COMPASS BANK | Exterran Corporation | Exterran Energy Solutions, LP | GOLDMAN SACHS BANK | INVESTMENT BANK | JPMORGAN CHASE BANK, NA | MUFG UNION BANK, NA | PNC BANK, NATIONAL ASSOCIATION | RAYMOND JAMES BANK, NA | REGIONS BANK | ROYAL BANK OF CANADA | SANTANDER BANK, NA | SUMITOMO MITSUI BANKING CORPORATION | TORONTO DOMINION (NEW YORK) LLC | Wells Fargo Bank, National Association 
								
								Document Date: 12/12/2016
								
								
								Governing Law:Texas
43) FIRST AMENDMENT TO CREDIT AGREEMENT AND WAIVERParties: INFUSYSTEM HOLDINGS, INC | INFUSYSTEM HOLDINGS, INC, INFUSYSTEM HOLDINGS USA, INC, INFUSYSTEM, INC, FIRST BIOMEDICAL, INC, IFC LLC | JPMORGAN CHASE BANK, NA 
								
								Document Date: 12/9/2016
								
								
								Governing Law:New York
44) AMENDMENT NO. 1 TO EMPLOYEEMENT AGREEMENT AND WAIVER OF GOOD REASON TERMINATION ELECTIONParties: CJ ENERGY SERVICES, INC. | CJ Energy Services, Ltd | Nabors Redline Ltd 
								
								Document Date: 12/6/2016

45) ELEVENTH AMENDMENT TO CREDIT AGREEMENT AND SIXTH AMENDMENT TO LIMITED WAIVER AGREEMENTParties: GLOBAL POWER EQUIPMENT GROUP INC. | BRADEN CONSTRUCTION SERVICES, INC | BRADEN HOLDINGS, LLC | BRADEN MANUFACTURING, LLC | BRANCH BANKING AND TRUST COMPANY | GLOBAL POWER EQUIPMENT GROUP INC | GLOBAL POWER PROFESSIONAL SERVICES INC | GLOBAL POWER TECHNICAL SERVICES, INC | GPEG, LLC | HETSCO HOLDINGS, INC | HETSCO, INC | JPMORGAN CHASE BANK, NA | PROFESSIONALS, LLC | STEAM ENTERPRISES LLC | US BANK NATIONAL ASSOCIATION | WELLS FARGO BANK, NATIONAL ASSOCIATION | WILLIAMS GLOBAL SERVICES, INC | WILLIAMS INDUSTRIAL SERVICES GROUP | WILLIAMS INDUSTRIAL SERVICES, LLC | WILLIAMS PLANT SERVICES, LLC | WILLIAMS SPECIALTY SERVICES, LLC 
								
								Document Date: 12/6/2016
								
								
								Governing Law:New York
46) AZURE MIDSTREAM PARTNERS, LP LIMITED DURATION WAIVER AGREEMENTParties: AZURE MIDSTREAM PARTNERS, LP | Section 915 Financial | Wells Fargo Bank, National Association 
								
								Document Date: 12/5/2016
								
								
								Governing Law:New York
47) WaiverParties: GREAT BASIN SCIENTIFIC, INC. | Great Basin Scientific, Inc 
								Law Firm: Schulte Roth
								Document Date: 12/2/2016
								
								
								Governing Law:New York
48) AMENDMENT AGREEMENT AND WAIVERParties: ENER-CORE, INC. | Ener-Core, Inc 
								
								Document Date: 12/2/2016
								
								
								Governing Law:New York
49) FIRST AMENDMENT TO LIMITED WAIVERParties: MEMORIAL PRODUCTION PARTNERS LP | Administrative Agent, Issuing Bank | ASSOCIATED BANK, NA | BETA OPERATING COMPANY, LLC | BMO HARRIS BANK, NA | BRANCH BANKING AND TRUST COMPANY | CADENCE BANK, NA | CANADIAN IMPERIAL BANK OF COMMERCE, NEW YORK BRANCH | CAPITAL ONE, NATIONAL ASSOCIATION | CARGILL, INCORPORATED | CITIBANK, NA | CITIZENS BANK, NA | COLUMBUS ENERGY, LLC | COMERICA BANK | COMPASS BANK | CREDIT AGRICOLE CORPORATE AND INVESTMENT BANK | DEUTSCHE BANK AG | GOLDMAN SACHS BANK | ING CAPITAL LLC | JPMORGAN CHASE BANK, NA | MEMORIAL ENERGY SERVICES LLC | MEMORIAL MIDSTREAM LLC | MEMORIAL PRODUCTION FINANCE CORPORATION | Memorial Production Operating LLC | Memorial Production Partners GP LLC | MEMP SERVICES LLC | Original Limited | REGIONS BANK | RISE ENERGY BETA, LLC | RISE ENERGY MINERALS, LLC | Rise Energy Operating, LLC | ROYAL BANK OF CANADA | SAN PEDRO BAY PIPELINE COMPANY | SANTANDER BANK, NA | SUNTRUST BANK | UBS AG | US BANK NATIONAL ASSOCIATION | Wells Fargo Bank, National Association | WHT CARTHAGE LLC | WHT Energy Partners LLC | ZB, NA DBA AMEGY BANK 
								Law Firm: Vinson Elkins
								Document Date: 12/1/2016
								
								
								Governing Law:New York
50) AMENDMENT NO. 7 AND WAIVERParties: OCI PARTNERS LP | American Money Management Corp | AMMC CLO 15, LIMITED | AMMC CLO 16, LIMITED | AMMC CLO 17, LIMITED | AMMC CLO IX, LIMITED | AMMC CLO XI, LIMITED | AMMC CLO XIII, LIMITED | BANK OF AMERICA, N.A. | BATTALION CLO 2007-I, LTD | BATTALION CLO III, LTD | Battalion CLO IV, LTD | Battalion CLO IX, LTD | Battalion CLO V, LTD | Battalion CLO VI, LTD | Battalion CLO VII, Ltd | Battalion CLO VIII, Ltd | Blue Shield | Brown Brothers Harriman  Co | CATAMARAN CLO 2013-1 LTD | CATAMARAN CLO 2014-1 LTD | CATAMARAN CLO 2014-2 LTD | CATAMARAN CLO 2015-1 LTD | Catlin RE Switzerland LTD | Catlin Underwriting Agencies LTD | FDP Series, Inc | Fire and Police Pension Fund | Franklin Floating Rate Master Trust | Franklin Global Investment Funds | Franklin Limited | Franklin Templeton Series II Funds | Franklin Templeton Variable Insurance | Galaxy XIX CLO, Ltd | Galaxy XX CLO, Ltd | JPMC Retirement Plan Brigade Bank | Kansas Public Employees Retirement System | KATONAH 2007-I CLO LTD | Katonah Debt Advisors, LLC | LCM Asset Management LLC | LCM X Limited Partnership | LCM XI Limited Partnership | LCM XII Limited Partnership | LCM XIII Limited Partnership | LCM XIV Limited Partnership | LCM XIX Limited Partnership | LCM XV Limited Partnership | LCM XVI Limited Partnership | LCM XVII Limited Partnership | LCM XVIII Limited Partnership | LCM XX Limited Partnership | Lincoln Variable Insurance | Muir Woods CLO, Ltd | OCI BEAUMONT LLC | OCI USA INC | OCP CLO 2012-2, Ltd | OCP CLO 2013-3, Ltd | OCP CLO 2013-4, Ltd | OCP CLO 2014-5, Ltd | OCP CLO 2014-6, Ltd | OCP CLO 2015-10, Ltd | OCP CLO 2015-8, Ltd | OCP CLO 2015-9, Ltd | OCP CLO 2016-11, Ltd | Onex Credit Partners, LLC | Oppenheimer Master Loan Fund, LLC | OppenheimerFunds, Inc | PineBridge Investments LLC | PineBridge Senior Secured Loan Fund Ltd | Sound Point CLO IV, Ltd | Sound Point CLO IX, Ltd | Sound Point CLO V, Ltd | Sound Point CLO XII, Ltd | Telos Asset Management LLC | Telos CLO 2013-3, Ltd | Telos CLO 2013-4, L 
								Law Firm: Latham Watkins;Cahill Gordon
								Document Date: 12/1/2016
								
								
								Governing Law:New York
 




Browse by StateGo directly to a specific page of results:123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960 
 
 

 












